ML20077A747

Forwards Revised Fda for Us ABWR Std Design,Per App O of 10CFR52 & Notice of Issuance of Fda

ML20077A747
Person / Time
Site:	05200001
Issue date:	11/23/1994
From:	Russell W Office of Nuclear Reactor Regulation
To:	Quirk J GENERAL ELECTRIC CO.
Shared Package
ML20077A750	List: ML20077A747
References
NUDOCS 9411250204
Download: ML20077A747 (4)

Text

1

. , November 23, 1994 l Mr. Joseph Quirk '

ABWR Certification Program Manager GE Nuclear Energy 175 Curtner Avenue, Mail Code-782 i San Jose, California 95125

Dear Mr. Quirk:

This letter transmits a revised final design approval (FDA) for the U.S. '

advanced boiling water reactor (ABWR) standard design, issued pursuant to Appendix 0 of Part 52 of Title 10 of the Code of Federal Reaulations. The FDA now has a term length of 15 years from the July 13, 1994, issuance of the original FDA and will expire on July 13, 2009, unless extended by the staff.

The staff has not changed any of its findings from those in the final safety evaluation report. A copy of the Notice of Issuance of FDA for the ABWR design, which has been sent to the federal Reaister for publication, is also enclosed for your information.

Sin William T. Russell, Director Office of Nuclear Reactor Regulation Docket No.52-001

Enclosures:

1. FDA for U.S. ABWR standard design

2. Federal Reaister Notice cc w/ enclosures:

See next page DISTRIBUTION:

Docket File PDST R/F WRussell/FMiraglia, 0-12G18 PDR DCrutchfield WTravers RBorchardt RArchitzel JNWilson SNinh DTang JMoore, 0-15B18 KCyr, 0-15B18 ACRS (11) WDean, EDO TBoyce PMagnanelli RZimmerman, 0-12G18 AThadani, 0-12G18 RWeisman, 0-15B18 BSweeney NRR Mailroom, 0-12G18 (YT 940189 &940204)

• SEE PREVIOUS CONCURRENCE OFC: PM:PDST:ADAR* LA:PDST ADAR* TECH EDITOR

• SC:PDST:ADAR* D:PDST:ADAR*

NAME: SMagruder:sg PMagnanelli RArchitzel RBorchardt DATE: 10/25/94 10/26/94 10/25/94 10/26/94 10/26/94 0FC: OGC* ADAR:NRR* b g h D:NRR l, f )

NAME: RWeisman DCrutchf / WRussell DATE: 11/09/94 10/27/94 lfh lk/h94 0FFICIAI prrnRR CADv. ,g;, DOCUMENT NAME: FDAYT.SM -

^

9411250204 941123 PDR ADOCK 05200001 T p' P, 7

. b) i 1 c

A PDR

Mr. Joseph Quirk Docket No.52-001 GE Nuclear Energy cc: Mr. Steven A. Hucik Mr. Ronald Simard, Director GE Nuclear Energy Advanced Reactor Programs 175 Curtner Avenue. Mail Code 782 Nuclear Energy Institute San Jose, California 95125 1776 Eye Street, N.W.

Suite 300 Mr. L. Gifford, Progiam Manager Washington, D.C. 20086 Regulatory Programs GE Nuclear Energy Mr. Victor G. Snell, Director 12300 Twinbrook Parkway Safety and Licensing Suite 315 AECL Technologies Rockville, Maryland 20852 9210 Corporate Boulevard Suite 410 Director, Criteria & Standards Division Rockville, Maryland 20850 Office of Radiation Programs U.S. Environmental Protection Agency Mr. Joseph R. Egan 401 M. Street, S.W. Egan & Associates, P.C. '

Washington, D.C. 20460 2300 N Street, N.W.

Washington, D.C. 20037-1138 Mr. Sterling Franks U. S. Department of Energy Barton Z. Cowan, Esq.

NE-42 Eckert Seamans Cherin & Mellott Washington, D.C. 20585 600 Grant Street 42nd Floor Pittsburgh, Pennsylvania 15219 Marcus A. Rowden, Esq.

Fried, Frank, Harris, Shriver & Jacobson Mr. B. A. McIntyre 1001 Pennsylvania Avenue, N.W. Advanced Plant Safety & Licensing Suite 800 Westinghouse Electric Corporation Washington, D.C. 20004 Energy Systems Business Unit Box 355 Jay M. Gutierrez, Esq. Pittsburgh, Pennsylvania 15230 Newman & Holtzinger, P.C.

1615 L Street, N.W.

Suite 1000 Washington, D.C. 20036 Mr. Steve Goldberg Budget Examiner 725 17th Street, N.W.

Room 8002 Washington, D.C. 20503 Mr. Frank A. Ross U.S. Department of Energy, NE-42 Office of LWR Safety and Technology 19901 Germantown Road Germantown, Maryland 20874

DOCKET NO.52-001 GE NUCLEAR ENERGY (GE)

U.S. ABWR STANDARD DESIGN FINAL DESIGN APPROVAL (FDA)

PURSUANT TO 10 CFR PART 52. APPENDIX 0 (1) GE has submitted to the Nuclear Regulatory Commission (NRC) staff, for its review, a standardized design for a major portion of a nuclear power facility of the type described in Section 50.22 of Title 10 of the Code of Federal Reaulations (10 CFR). GE's standard design is described in the U.S. ABWR standard safety analysis report (SSAR), including Amend-ments 1 through 35 thereto.

(2) The SSAR contains design information required by 10 CFR Part 52, Appendix 0, Paragraph 3, for a standard design. The U.S. ABWR standard design, whose scope is defined in SSAR Section 1.1.2, is for a nuclear power facility with a rated reactor core power level of 3926 megawatts thermal.

(3) The NRC staff and the Advisory Committee on Reactor Safeguards (ACRS) have reviewed the U.S. ABWR standard design. The findings of the staff's evaluation of the U.S. ABWR standard design are presented in the final safety evaluation report (FSER) dated June 1994. The ACRS reported on the application for design certification in a letter dated April 14, 1994 (see Chapter 21 of the FSER), as required by 10 CFR 52.53.

(4) On the basis of its review and the findings in the FSER, the staff concludes that the information in the SSAR, with respect to the U.S.

ABWR standard design as described in Paragraph 2 above, complies with the requirements of 10 CFR Part 52, Appendix 0.

(5) The U.S. ABWR standard design is acceptable for use as a reference design for construction permit and operating license applications and combined license applications for facilities that are located at sites whose characteristics are within the envelope of site parameters given in the SSAR, and the out-of-scope portions of the plant that interface with the approved design conform to the interface requirements given in the SSAR.

(6) This FDA and all applications for operating licenses incorporating it by reference are subject to all applicable provisions of the Atomic Energy Act, as amended, and the rules and regulations and orders of the Commis- l sion now or hereafter in effect. l l

~ - . _

I l

(7) This FDA does not constitute a commitment to issue a permit, design certification, or license, or in any way affect the authority of the l Commission, the Atomic Safety and Licensing Board, and other presiding l officers ir. any proceeding pursuant to 10 CFR Part 2.

(8) This FDA is effective as of its date of issuance and shall expire on i July 13, 2009, unless extended by the staff. The expiration of this FDA shall not affect its use in applications docketed before such date.

Dated in Rockville, Maryland, this 23rd day of November- , 1994.

FOR THE NUCLEAR REGULATORY COMMISSION h

William T. Russell, Director Office of Nuclear Reactor Regulation l

l l

l l

I l

I l

I 1